Acute and Chronic Liver Diseases

Introduction; R. Schmid. <strong>Section I: Viral Hepatitis. 1.</strong> Hepatitis A and E: Molecular Biology; R.H. Purcell, S.U. Emerson. <strong>2.</strong> Hepatitis B Viral Variants; J.R. Wands, et al. <strong>3.</strong> The Natural History of Chronic Viral Hepatitis Type B and D; M. Rizzetto. <strong>4.</strong> Hepatitis C Virus: Molecular Biology and Genetic Variability; C. Brechot. <strong>5.</strong> Hepatitis C: Epidemiology and Clinical Course; H.J. Alter.<strong> 6.</strong> Hepatitis C: Diagnosis and Therapy; A. Alberti, et al.<strong> Section II: Biliary Liver</strong> <strong>Diseases. 7.</strong> Molecular Pathogenesis of Cholestasis; J.L. Boyer. <strong>8.</strong> Biliary Liver Diseases: Diagnosis, Natural Course and Therapy; G. Paumgartner, U. Beuers. <strong>Section III: Toxic Liver Diseases. 9.</strong> Pathogenesis and Natural Course of Alcoholic Liver Disease; C.S. Lieber. <strong>10.</strong> Therapy of Alcoholic Liver Disease; C. Oneta, et al. <strong>11.</strong> Importance of Drug Metabolism for Drug Toxicity; U.A. Meyer. <strong>12.</strong> Drug-Induced Hepatotoxicity: Clinical Presentation, Pathogenesis, Risk Factors, Diagnosis and Treatment; S. Krahenbuhl, N. Kaplowitz. <strong>Section</strong> <strong>IV: Metabolic Liver Diseases. 13.</strong> Molecular Pathogenesis of Hemochromatosis; C. Camaschella, et al. <strong>14.</strong> Hemochromatosis - Recent Diagnostic and Therapeutic Aspects; P. Brissot, et al. <strong>15.</strong> Wilson's Disease: Molecular Pathogenesis; T.C. Gilliam.<strong> 17.</strong> Molecular Pathogenesis of Hepatic Acute Porphyrias; B. Grandchamp, et al. <strong>18.</strong> The Clinical Diagnosis, Prevention and Management of the Hepatic Porphyrias; R.J. Hift, et al.<strong> 19.</strong> Molecular Pathogenesis of Alpha-1-Antitrypsin Deficiency; D.H. Perlmutter. <strong>20.</strong> Diagnosis, Clinical Course and Therapy of Alpha-1-Antitrypsin Deficiency; J. Carlson.<strong> Section V: Autoimmune Hepatitis. 21.</strong> Viruses and Autoimmunity: Hepatitis as a Model. International Hans Popper Award Lecture 1995; M.P. Manns. <strong>22.</strong> Molecular Pathogenesis of Autoimmune Hepatitis; M.P. Manns. <strong>23.</strong> Autoimmune Hepatitis Diagnosis, Natural Course and Therapy; I.G. McFarlane.<strong> Section VI: Fulminant Liver</strong> <strong>Failure. 24.</strong> Molecular Biology of Cell Damage and Death; V.J. Desmet. <strong>25.</strong> Clinical Management of Fulminant Hepatic Failure; R. Williams. <strong>26.</strong> Fulminant Liver Failure: Prediction of Outcome; G. Grimm, et al. <strong>27.</strong> Liver Transplantation in Fulminant Liver Failure; B. Launois, et al. <strong>Section VII: Liver Cirrhosis and Hepatocellular Carcinoma. 28.</strong> Molecular Fibrogenesis in Liver Injury; S.L. Friedman. <strong>29.</strong> Liver Regeneration and the Pathogenesis of Hepatocellular Carcinoma; N. Fausto.<strong> 30.</strong> Risk Factors and Early Diagnosis of Hepatocellular Carcinoma; M. Colombo. <strong>31.</strong> Cirrhosis and Hepatocellular Carcinoma Medical and Interventional Therapy; M.C. Kew.<strong> 32.</strong> Surgical Therapy in Europe of Hepatocellular Carcinoma in Cirrhosis; H. Bismuth, J.S. Raccuia. <strong>33.</strong> Surgical Therapy of Hepatocellular Carcinoma in China; Z.Y. Tang. Index.